Home - AVS Pulse, Inc
AVS Receives IDE Approval from FDA for Pivotal Intravascular Lithotripsy Study. BOSTON–(BUSINESS WIRE)–Amplitude Vascular Systems (AVS), a medical device …
AVS' PIVL™ System in growing PAD market; Details on Medtech's …
AVS’ PIVL™ System in growing PAD market; Details on Medtech’s new digital playbook. AVS Chief Operating Officer, Sean Gilligan, recently sat down with Tom Salemi on the DeviceTalks …
AVS Receives IDE Approval from FDA for Pivotal Intravascular ...
The POWER-PAD-II clinical study will evaluate the safety and efficacy of AVS’s Pulse IVL™ System for the treatment of patients with severely calcified peripheral arterial disease in the …
AVS Enrolls First Patient in U.S. Pivotal Intravascular Lithotripsy ...
BOSTON–(BUSINESS WIRE)–Amplitude Vascular Systems , a medical device company focused on safely and effectively treating severely calcified arterial disease, announced today that it …
Press Release Archives - AVS Pulse, Inc
Aug 20, 2024 · BOSTON–(BUSINESS WIRE)–AVS, an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease with its PIVL™ …
Pulsatile Intravascular Lithotripsy: A Novel Mechanism for …
Based on the histological findings from our early cadaveric studies, Amplitude Vascular Systems‘ pulsatile intravascular lithotripsy (PIVL) mechanism is not only capable of shattering calcium, …
AVS’s Pulsatile Intravascular Lithotripsy Technology Attracts an ...
The funding will continue to support clinical trials for the company’s device for pulsatile intravascular lithotripsy (PIVL) in peripheral cases, while advancing preclinical work for an …
AVS Raises $20 Million in Series B Round to Advance Pulsatile ...
The new funding will accelerate clinical trial timelines for the company’s device for peripheral application in pulsatile intravascular lithotripsy (PIVL) cases and advance development and …
Contact - AVS Pulse, Inc
AVS Enrolls First Patient in U.S. Pivotal Intravascular Lithotripsy Study. BOSTON–(BUSINESS WIRE)–Amplitude Vascular Systems (AVS), a medical device company focused on safely and …
AVS Completes a $36M Series B Financing Ahead of IVL U.S.
The funding will support the U.S. peripheral commercial launch as well as U.S. coronary and carotid IDE trials for the company’s Pulse Intravascular Lithotripsy™ (PIVL™) device.